 Oramed Pharmaceuticals Inc. Nasdaq: ORMP and TASE: ORMP a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the European Patent Office has indicated its intent to grant the Company a patent for its invention titled Methods and Compositions for Oral Administration of Proteins, addressing oral compositions comprising protease inhibitors, which are a key component of the platform technology that protects therapeutic proteins in the digestive system. 